VB-703

N/A

Report date: 2023/04/20 09:43:49
NME

Base Information

Drug NameVB-703
Drug Alias NameVB-703
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 2 antagonistsToll like receptor 4 antagonists
TargetsToll like receptor 2Toll like receptor 4
Therapy Area/IndicationsRenal fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVascular Biogenics Ltd. Operating As Vbl Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesVascular Biogenics Ltd. Operating As Vbl Therapeutics
Inactive CompaniesN/A
Active IndicationsRenal fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A